These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 24992394)
1. A Delphi study of pharmacotherapy for noncystic fibrosis bronchiectasis. Judson MA; Chaudhry H; Compa DR; OʼDonnell AE Am J Med Sci; 2014 Nov; 348(5):387-93. PubMed ID: 24992394 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis. Amaro R; Panagiotaraka M; Alcaraz V; Torres A Expert Rev Respir Med; 2018 Aug; 12(8):683-691. PubMed ID: 30010445 [TBL] [Abstract][Full Text] [Related]
3. Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: Is there evidence? Snijders D; Fernandez Dominguez B; Calgaro S; Bertozzi I; Escribano Montaner A; Perilongo G; Barbato A Int J Immunopathol Pharmacol; 2015 Jun; 28(2):150-9. PubMed ID: 26078380 [TBL] [Abstract][Full Text] [Related]
4. Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children. Snijders D; Calgaro S; Bertozzi I; Quartesan S; Kozuh I; Lunardi F; Barbato A Int J Immunopathol Pharmacol; 2013; 26(2):529-34. PubMed ID: 23755770 [TBL] [Abstract][Full Text] [Related]
5. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis. Chorepsima S; Kechagias KS; Kalimeris G; Triarides NA; Falagas ME Drug Des Devel Ther; 2018; 12():4059-4066. PubMed ID: 30568427 [TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Schutt AC; Bullington WM; Judson MA Respir Med; 2010 May; 104(5):717-23. PubMed ID: 20089389 [TBL] [Abstract][Full Text] [Related]
7. New therapeutic options for noncystic fibrosis bronchiectasis. Yap VL; Metersky ML Curr Opin Infect Dis; 2015 Apr; 28(2):171-6. PubMed ID: 25692269 [TBL] [Abstract][Full Text] [Related]
8. The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial. Liao Y; Wu Y; Zi K; Shen Y; Wang T; Qin J; Chen L; Chen M; Liu L; Li W; Zhou H; Xiong S; Wen F; Chen J BMC Pulm Med; 2022 Nov; 22(1):401. PubMed ID: 36344940 [TBL] [Abstract][Full Text] [Related]
10. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis. Tay GT; Reid DW; Bell SC Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593 [TBL] [Abstract][Full Text] [Related]
11. Gender differences in non-cystic fibrosis bronchiectasis severity and bacterial load: the potential role of hormones. Brooke-Hollidge A; Conway J; Lewis A Ther Adv Respir Dis; 2021; 15():17534666211035311. PubMed ID: 34520299 [TBL] [Abstract][Full Text] [Related]
12. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B; Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664 [TBL] [Abstract][Full Text] [Related]
13. Inhaled antibiotics in non-cystic fibrosis bronchiectasis: A meta-analysis. Xu L; Zhang F; Du S; Yu Q; Chen L; Long LH; Li YM; Jia AH Pharmazie; 2016 Sep; 71(9):491-498. PubMed ID: 29441843 [TBL] [Abstract][Full Text] [Related]
20. Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis. Daviskas E; Anderson SD; Young IH Respir Med; 2010 Mar; 104(3):371-7. PubMed ID: 19914814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]